STING1 and neoplasm: Arwert et al. demonstrated that the transcytosis of cytoplasm from cancer cells into CAFs can activate the STING pathway in CAFs, particularly in tumors such as squamous cell carcinoma, thereby promoting anti-tumor immune responses42.